Improving Detection Sensitivity
Scientists at Imagion Biosystems, along with our collaborators, continue to push back the boundaries of detection limits in our quest to improve on the early…
Detecting Small Tumors
Cancerous tumors start small and grow larger over time, adding defensive mechanisms that make them resistant to treatments and more deadly. So, to find cancers…
Earlier Detection Means An Earlier Cure
Data from the US National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program, charted below, illustrates the critical importance of…
Detecting Cancer Cells with Stealthy Nanoparticles
For effective use in detecting specific types of cancer, tumor-targeting nanoparticles must evade the immune system, remain intact for a clinically relevant…
Her2+ Breast Cancer Detection
For effective use in detecting specific types of cancer, tumor-targeting nanoparticles must evade the immune system and remain intact for a clinically relevant…
New Nanoparticle Technologies Arise from MD Anderson Collaboration
Rebeca Romero Aburto PhD is an Imagion Biosystems research collaborator and a post-doctoral fellow at the University of Texas MD Anderson Cancer Center. As an…
Say Hello to Imagion Biosystems
News! The nanotechnology-based cancer diagnostics-development company known as Senior Scientific is now Imagion Biosystems. The company has spun out from its…